N. Mert-Ozupek Et Al. , "The enhanced permeability and retention (EPR) effect of caulerpin and heparin on doxorubicin and liposomal doxorubicin: a nanotherapeutical and cancer efficiency approach," FEBS OPEN BIO , vol.8, pp.260, 2018
Mert-Ozupek, N. Et Al. 2018. The enhanced permeability and retention (EPR) effect of caulerpin and heparin on doxorubicin and liposomal doxorubicin: a nanotherapeutical and cancer efficiency approach. FEBS OPEN BIO , vol.8 , 260.
Mert-Ozupek, N., Baran, B., Bayrak, S., Calibasi-Kocal, G., & BAŞBINAR, Y., (2018). The enhanced permeability and retention (EPR) effect of caulerpin and heparin on doxorubicin and liposomal doxorubicin: a nanotherapeutical and cancer efficiency approach. FEBS OPEN BIO , vol.8, 260.
Mert-Ozupek, N. Et Al. "The enhanced permeability and retention (EPR) effect of caulerpin and heparin on doxorubicin and liposomal doxorubicin: a nanotherapeutical and cancer efficiency approach," FEBS OPEN BIO , vol.8, 260, 2018
Mert-Ozupek, N. Et Al. "The enhanced permeability and retention (EPR) effect of caulerpin and heparin on doxorubicin and liposomal doxorubicin: a nanotherapeutical and cancer efficiency approach." FEBS OPEN BIO , vol.8, pp.260, 2018
Mert-Ozupek, N. Et Al. (2018) . "The enhanced permeability and retention (EPR) effect of caulerpin and heparin on doxorubicin and liposomal doxorubicin: a nanotherapeutical and cancer efficiency approach." FEBS OPEN BIO , vol.8, p.260.
@article{article, author={N. Mert-Ozupek Et Al. }, title={The enhanced permeability and retention (EPR) effect of caulerpin and heparin on doxorubicin and liposomal doxorubicin: a nanotherapeutical and cancer efficiency approach}, journal={FEBS OPEN BIO}, year=2018, pages={260} }